![](/img/cover-not-exists.png)
P-167 * Risk factors for febrile neutropenia in patients with unresectable pancreatic cancer receiving FOLFIRINOX as the first-line treatment
Sasaki, M., Ueno, H., Kuchiba, A., Koga, F., Shiba, S., Sakamoto, Y., Kondo, S., Morizane, C., Okusaka, T.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.167
Date:
June, 2015
File:
PDF, 34 KB
english, 2015